In addition, GSK-3β activities that are required for N-terminus hyperphosphorylation-mediated degradation of β-catenin are downregulated due to increased GSK-3β-Ser9 phosphorylation in DCLK1-overexpressing hepatoma cells. Here, DCLK1 is linked to hepatocellular carcinoma.